Increased incidence of cancer in adult Gaucher disease in Western Europe.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood Cells, Molecules & Diseases

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BCMD.2005.08.004PMID 16246599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gaucher's disease and benign monoclonal gammapathy. A case report with immunofluorescence study of bone marrow and spleen.

  2009cited by this paper
• Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

  2009cited by this paper
• Association of Gaucher's disease and lymphoid malignancy in 2 children.

  2009cited by this paper
• Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease.

  2009cited by this paper
• Acute leukaemia and Gaucher's disease.

  2009cited by this paper
• Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

  2002cited by this paper
• Screening for Hepatocellular Carcinoma

  2002cited by this paper
• Incidence of Cancer in the Netherlands 1998

  2002cited by this paper
• Gaucher's disease.

  2001cited by this paper
• Surgical strategies in the management of hilar cholangiocarcinoma

  2000cited by this paper
• Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria

  2000cited by this paper
• Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature

  1999cited by this paper
• Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy.

  1999cited by this paper
• Cytokines in Gaucher's disease.

  1999cited by this paper
• Screening for hepatocellular carcinoma

  1998cited by this paper
• Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.

  1997cited by this paper
• Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease.

  1997cited by this paper
• A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency

  1996cited by this paper
• Increased risk of cancer in patients with gaucher disease

  1993cited by this paper
• Gaucher's disease associated with chronic lymphocytic leukemia.

  1993cited by this paper
• Gaucher's disease associated with monoclonal gammapathy of undetermined significance: a case report.

  1993cited by this paper
• Gaucher Disease: Clinical, Laboratory, Radiologic, and Genetic Features of 53 Patients

  1992cited by this paper
• [Coincidence of Gaucher disease with primary hepatocellular carcinoma].

  1991cited by this paper
• Polyclonal B‐cell lymphocytosis and hypergammaglobulinemia in patients with gaucher disease

  1988cited by this paper
• Adult Gaucher disease in association with acute leukaemia.

  1987cited by this paper
• Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.

  1986cited by this paper
• Interaction between a serum factor and T lymphocytes in gaucher disease

  1985cited by this paper
• Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and b‐cell proliferations?

  1984cited by this paper
• Monoclonal gammopathies in the adult population of Finistère, France.

  1982cited by this paper
• Coexistence of Gaucher's disease and multiple myeloma.

  1982cited by this paper
• beta-Glucosidase assays in the diagnosis of Gaucher's disease.

  1982cited by this paper
• Gaucher's disease associated with chronic lymphocytic leukemia.

  1982cited by this paper
• Gaucher's disease: a disease with chronic stimulation of the immune system.

  1982cited by this paper
• Coexistence of IgA myeloma and Gaucher's disease.

  1980cited by this paper
• Gaucher's disease.

  1980cited by this paper
• Gaucher's disease associated with Hodgkin's disease.

  1980cited by this paper
• Amyloidosis. An unusual complication of Gaucher's disease.

  1978cited by this paper
• Coexistence of Hoclgkin’s Disease and Gaucher’s Disease

  1976cited by this paper
• Coexistence of Hodgkin's disease and Gaucher's disease.

  1976cited by this paper
• Gaucher's disease associated with chronic lymphocytic leukaemia, gout and carcinoma

  1975cited by this paper
• Association of Hodgkin disease and Gaucher disease.

  1974cited by this paper
• Gaucher's disease.

  1973cited by this paper
• Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.

  1972cited by this paper
• Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases.

  1968cited by this paper
• METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

  1965cited by this paper
• A Deficiency of Glucocerebrosidase in Gaucher's Disease

  1965cited by this paper

• Liver involvement in Gaucher disease in children: A literature review and clinical observations

  2025cites this paper
• S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion

  2025cites this paper
• Cytotoxic lymphocyte effector function is unaffected in patients with Gaucher disease

  2025cites this paper
• S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion

  2025cites this paper
• Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study

  2025cites this paper
• French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease

  2025cites this paper
• A large long‐term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours

  2025cites this paper
• Oncological Aspects of Lysosomal Storage Diseases

  2024influential citation
• S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0

  2023cites this paper
• S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion

  2023cites this paper
• Genetics of enzymatic dysfunctions in metabolic disorders and cancer

  2023cites this paper
• Transition seltener Leberkrankheiten im Kindesalter – was kommt auf die Hepatologie zu?

  2023cites this paper
• The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature

  2023cites this paper
• Cancer Risk in Patients with Gaucher Disease Using Real-World Data

  2023cites this paper
• S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0

  2023cites this paper
• Multiple myeloma occurring in a case of Niemann‐Pick disease Type B: A pathophysiological link?

  2022cites this paper
• Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher disease

  2022cites this paper
• S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms

  2022cites this paper
• Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma

  2022cites this paper
• Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications

  2022cites this paper
• Natural history and management of liver dysfunction in lysosomal storage disorders

  2022cites this paper
• Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer

  2022influential citation
• A simultaneous diagnosis of multiple myeloma and Gaucher disease

  2022cites this paper
• Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma

  2022cites this paper
• Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry

  2022cites this paper
• Mortality in patients with alpha-mannosidosis: a review of patients’ data and the literature

  2022cites this paper
• Early-Onset Colorectal Cancer in a Young Woman with Type 1 Gaucher Disease

  2022cites this paper
• Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets

  2022cites this paper
• C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages

  2021cites this paper
• Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study

  2021cites this paper
• Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus.

  2021cites this paper
• Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease

  2021cites this paper
• Lysosomal Storage Disorders

  2021cites this paper
• Role of lysosomes in physiological activities, diseases, and therapy

  2021cites this paper
• Dual Cancer in a Patient with Type 1 Gaucher Disease: Case Report and Literature Review

  2021cites this paper
• Proteomic biomarkers in Gaucher disease

  2020cites this paper
• Gaucher's Disease In A 72-Year-Old Man: Case Report And Review Of Literature

  2020cites this paper
• Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses

  2020cites this paper
• Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist.

  2020cites this paper
• Synchronous multiple myeloma and Gaucher disease.

  2020cites this paper
• Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry

  2020cites this paper
• Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United States

  2020influential citation
• Genetic parkinsonisms and cancer: a systematic review and meta-analysis

  2020cites this paper
• Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease

  2020cites this paper
• Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease

  2020influential citation
• Inhibition of β-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction.

  2020cites this paper
• A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma

  2019cites this paper
• Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development

  2019cites this paper
• Gaucher’s disease and liver involvement: A review and our experience

  2019cites this paper
• Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma

  2019cites this paper
• Gaucher disease, myelodysplastic syndrome and ICUS.

  2019cites this paper
• A case of bony lytic lesions in a patient with Gaucher disease

  2019cites this paper
• Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy

  2019cites this paper
• Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement

  2019cites this paper
• Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder

  2019cites this paper
• La maladie de Gaucher : quand y penser ?

  2019cites this paper
• The unusual association between Neuroblastoma and Gaucher Disease: Case report and review of the literature.

  2018cites this paper
• Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.

  2018cites this paper
• Chapter 6 – Genetic Syndromes With an Associated Cancer Risk

  2018cites this paper
• Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.

  2018cites this paper
• Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease.

  2018cites this paper
• Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1.

  2018cites this paper
• Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy.

  2018cites this paper
• Liver involvement in Gaucher disease - Review and clinical approach.

  2018cites this paper
• Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1.

  2018cites this paper
• Ironing out pathophysiological aspects of Gaucher disease

  2018cites this paper
• Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

  2018cites this paper
• Oncogenic effects of germline mutations in lysosomal storage disease genes

  2018cites this paper
• Immunoglobulin Heavy Chain Gene Rearrangements in Patients with Gaucher Disease

  2018cites this paper
• Recent advances in the diagnosis and management of Gaucher disease

  2018cites this paper
• Hepatocellular carcinoma in Gaucher disease: an international case series

  2018cites this paper
• Lysosomal Storage Disorders and Malignancy

  2017cites this paper
• Gaucher disease epidemiology and natural history: a comprehensive review of the literature

  2017cites this paper
• Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry

  2017cites this paper
• Fabry disease and incidence of cancer

  2017cites this paper
• Gaucher disease: risk stratification and comorbidities

  2017cites this paper
• Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment

  2017cites this paper
• Characterisation of pathogenic pathways within the bone microenvironment of Gaucher disease which contribute to bone pathology and haematological malignancy

  2017influential citation
• Gaucher disease: Progress and ongoing challenges.

  2017cites this paper
• A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

  2017cites this paper
• Lysosomal storage diseases

  2016cites this paper
• Hepatobiliary Pseudotumors Consisting of Nonneoplastic Hematopoietic Cells and Cells of the Macrophage Lineage

  2016cites this paper
• Hematological manifestations and complications of Gaucher disease

  2016cites this paper
• From rare to common and back again: 60years of lysosomal dysfunction.

  2016cites this paper
• Glucosylceramidases and malignancies in mammals.

  2016cites this paper
• Activated and Memory T Lymphocytes in Children with Gaucher Disease

  2016cites this paper
• Investigating rare haematological disorders - A celebration of 10 years of the Sherlock Holmes symposia

  2016cites this paper
• Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease.

  2016cites this paper
• Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population

  2016cites this paper
• Maladie de Gaucher

  2016cites this paper
• Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications.

  2016cites this paper
• Haematologic manifestations of Gaucher’s disease (Review of literature)

  2016cites this paper
• Gaucher disease: Review, epidemiology and modelling of the biological and clinical markers evolution

  2016cites this paper
• Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.

  2016cites this paper
• Understanding the natural history of Gaucher disease

  2015cites this paper
• Mesenteric and Mediastinal Lymphadenopathy in Egyptian Children With Gaucher Disease Types 1 and 3 Treated With Enzyme Replacement Therapy

  2015cites this paper
• Clinical manifestations and management of Gaucher disease.

  2015cites this paper
• A Rare Condition in Haematological Practice – Gaucher Disease

  2015cites this paper
• Guía para diagnóstico y tratamiento de la Enfermedad de Gaucher Guidelines for diagnosis and treatment of Gaucher Disease

  2015cites this paper
• Gaucher disease and comorbidities: B‐cell malignancy and parkinsonism

  2015cites this paper